To protect public health, at least 15 products manufactured by Universal Meditech are being recalled over "concerns that the tests may not be safe and effective," according to the Food and Drug Administration.

With employees delaying their retirement due to inflation and market volatility, many are interested in guaranteed lifetime income investment options included as part of a target date fund.

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.

A group of four bipartisan senators, including Sen. Charles Grassley, sent a letter to tax commissioners over concerns that these hospitals may not be providing charity care to communities as required for their tax-exempt status.